Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity
The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Abstract
Introduction: Although the hepatotoxicity of acetaminophen is a well-known problem, the search for reliable biomarker of toxicity is still a current issue as clinical tools are missing to assess patients intoxicated following chronic use, sequential ingestion, use of modified release formulations or in case of delayed arrival to hospital. The need for new specific and robust biomarkers for acetaminophen toxicity has prompted many studies exploring the use of blood levels of acetaminophen derivatives, mitochondrial damage markers, liver cell apoptosis and/or necrosis markers and circulating microRNAs.Areas covered: In this review, we present a concise overview of the most promising biomarkers currently under evaluation including descriptions of their properties with respect to exposure type, APAP specificity, and potential clinical application. In addition, we illustrate the power of new technologies for biomarker research and describe their current application to the field of acetaminophen-induced hepatotoxicity.Expert opinion: Recently the use of extracellular vesicles isolation in combination with omics techniques has opened a new perspective to the field of biomarker research. However, the potential of those new technologies for the prediction and monitoring of hepatic diseases and acetaminophen toxicity has not yet been fully taken into consideration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ALT and AST are hepatic enzymes that are released into the blood following hepatic cellular damage and are used to diagnose or exclude acute liver injury [42,76].”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [42]
In the citing paper
“After an acute overdose ALT/AST may increase after 8 h [42], however they can remain within the normal range for up to 24 h before hepatotoxicity becomes evident [82].”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [42]
In the citing paper
“Acetylcysteine therapy should be initiated within 8 h of ingestion to be most effective (described below, Section 4.2) [42].”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [42]
In the citing paper
“INR is used to determine the severity of hepatotoxicity as the liver is responsible for the production of many clotting factors [42].”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [42]
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834 · cited 2×
“While initially thought to result from the breakdown of dead cells, both exosomes andmicroparticles have been shown to be secreted in a controlledmanner from healthy cells and to be mediators of cell-to-cell communication [115,116].”
BackgroundExtracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099 · cited 1×
“upon fusion of vesicle-containing endosomes with the plasma membrane (reviewed by [113]).”
BackgroundCirculating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969 · cited 1×
“MicroRNAs show a remarkable stability in serum and plasma samples [75] and, as their expression is often affected in cancer and other diseases (reviewed by [76–78]), they constitute an interesting new class of biomarkers (reviewed by [79]).”
BackgroundRegulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462 · cited 2×
“Micro-RNA expression and processing are themselves tightly regulated [64], and both tissue and process specific [69,70].”
BackgroundMicroarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
Widespread changes in protein synthesis induced by microRNAs
Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., & Rajewsky, N. (2008) · Nature · doi:10.1038/nature07228 · Cited by 3,429
Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019055108 · Cited by 3,294 · cited 1×
“Circulating microRNAs are found in complex with highly stable protein complexes containing the Argo2 protein (component of the RISC complex) or incorporated inside small extracellular vesicles [72,73].”
BackgroundThe MicroRNA Spectrum in 12 Body Fluids
Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., How Huang, K., Jen Lee, M., Galas, D. J., & Wang, K. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147405 · Cited by 2,477 · cited 1×
“Micro-RNAs are mostly found inside cells, however low levels of microRNAs are present in body fluids such as blood or urine [71].”
BackgroundCharacterization of extracellular circulating microRNA
Turchinovich, A., Weiz, L., Langheinz, A., & Burwinkel, B. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr254 · Cited by 1,941 · cited 2×
“Their release to the circulation is believed to originate both from a regulated process mediating intercellular communication and from passive release upon cell death [72,74].”
Background
Research works printed but not linked: 7
- Bacle A, 2019, Eur J Clin Pharmacol, 10
- Brok J, 2006, Cochrane Database Syst Rev, 2, CD003328
- Lindena J, 1986, J Clin Chem Clin Biochem, 24, 35
- Wong A, 2017, Clin Toxicol (Phila), 27, 1
- Dear JW, 2017, Lancet Gastroenterol Hepatol
- Yu D, 2017, Arch Toxicol
- Safaei A, 2016, Gastroenterol Hepatol Bed Bench, 9, 158
Cited by
Chidiac, A. S., Buckley, N. A., Noghrehchi, F., & Cairns, R. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2223959 · Cited by 215
“After an acute overdose ALT/AST may increase after 8 h [42], however they can remain within the normal range for”
BackgroundMethodInfluentialMechanism of Idiosyncratic Drug Induced Liver Injury (DILI): Unresolved Basic Issues
Teschke, R., & Uetrecht, J. (2021) · Annals of Translational Medicine · doi:10.21037/atm-2020-ubih-05 · Cited by 58
“Future studies may be useful for elucidating initial mechanistic steps of liver injury (39,40,42-50).”
BackgroundResveratrol promotes liver regeneration in drug-induced liver disease in mice
de Moraes, A. C. N., de Andrade, C. B. V., Ramos, I. P., Dias, M. L., Batista, C. M. P., Pimentel, C. F., de Carvalho, J. J., & Goldenberg, R. C. D. S. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110185 · Cited by 37
Liu, L., Li, X., Huang, C., Bian, Y., Liu, X., Cao, J., Qu, W., & Miao, L. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1758060 · Cited by 24
Ding, C., & Zhu, H. (2020) · Environmental Toxicology · doi:10.1002/tox.22990 · Cited by 17
“Actually, APAP-resulted hepatic toxicity is still the primary reason that druginduced acute liver failure in both developed and developing countries.(6,7) APAP-induced hepatotoxicity is mainly caused by the excessive accumulation of N-acetyl-p-benzoquinone imine (NAPQI), a toxic reactive metabolite of APAP that is bio…”
Background
Metadata
- Authors
- Gloor, Y., Schvartz, D., & F.Samer, C.
- Affiliations
- University of Geneva (CH)
- Division of clinical pharmacology and toxicology, Geneva University Hospital, Geneva, Switzerland
- Corresponding author
- Gloor, Yvonne
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2019-07-15
- Volume
- 15
- Issue
- 8
- Pages
- 659-669
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2958934539
- Cited by
- 18
- References
- 127
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 1
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Drug Metabolism & Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- paracetamol, hepatotoxicity, biomarkers, apoptosis, necrosis, circulating microRNAs, extracellular vesicles, omics, drug-induced liver injury, modified-release formulation
- MeSH terms
- Acetaminophen, Animals, Humans, Mitochondria, Research Design, Biomarkers, Apoptosis, Analgesics, Non-Narcotic, MicroRNAs, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity. https://app.cochat.ai/papers/10.1080/17425255.2019.1642323
- The paper
- Gloor, Y., Schvartz, D., & F.Samer, C. (2019). Old problem, new solutions: biomarker discovery for acetaminophen liver toxicity. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2019.1642323
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.